These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35868306)

  • 41. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies.
    Hou HA; Tien HF
    J Biomed Sci; 2020 Jul; 27(1):81. PubMed ID: 32690020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
    Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
    Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis.
    Chashchina A; Märklin M; Hinterleitner C; Salih HR; Heitmann JS; Klimovich B
    Sci Rep; 2021 Sep; 11(1):18012. PubMed ID: 34504191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index.
    Li Y; Thomas D; Deutzmann A; Majeti R; Felsher DW; Dill DL
    Sci Rep; 2019 Nov; 9(1):16775. PubMed ID: 31727951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of newly diagnosed acute myeloid leukemia with myelodysplasia related changes and elderly acute myeloid leukemia following decitabine therapy in combination with priming regimen.
    Lai B; Mu Q; Zhang Y; Chen Y; Yan X; Ouyang G
    Hematology; 2021 Dec; 26(1):751-757. PubMed ID: 34555298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
    Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
    Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
    Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
    Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16.
    Dembitz V; Lalic H; Tomic B; Smoljo T; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
    Int J Hematol; 2022 Jan; 115(1):43-53. PubMed ID: 34546543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia.
    Wang M; Lindberg J; Klevebring D; Nilsson C; Lehmann S; Grönberg H; Rantalainen M
    J Natl Cancer Inst; 2018 Oct; 110(10):1094-1101. PubMed ID: 29506270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of mast cells as a candidate significant target of immunotherapy for acute myeloid leukemia.
    Jia M; Zhang H; Wang L; Zhao L; Fan S; Xi Y
    Hematology; 2021 Dec; 26(1):284-294. PubMed ID: 33648435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
    Huang R; Liao X; Li J; Wei J; Su X; Lai X; Liu B; Zhu F; Huang Y; Li Q
    Oncol Rep; 2019 May; 41(5):2876-2888. PubMed ID: 30896832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress.
    Xiang W; Lam YH; Periyasamy G; Chuah C
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
    Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
    Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.
    Shi J; Fu H; Jia Z; He K; Fu L; Wang W
    EBioMedicine; 2016 Dec; 14():55-64. PubMed ID: 27916548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
    Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
    Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytotoxicity Assessment and Apoptosis-related Gene Profiling of Antibody Treated Acute Myeloid Leukemia (AML) and Acute Lymphocytic Leukemia (ALL) Cancerous Cell Lines.
    Habibi-Anbouhi M; Kafi Z; Ghazizadeh L; Kharazi S; Behdani M; Faraji F; Shokrgozar MA
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(6):679-687. PubMed ID: 32245312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intra-heterogeneity in transcription and chemoresistant property of leukemia-initiating cells in murine Setd2
    Song J; Du L; Liu P; Wang F; Zhang B; Xie Y; Lu J; Jin Y; Zhou Y; Lv G; Zhang J; Chen S; Chen Z; Sun X; Zhang Y; Huang Q
    Cancer Commun (Lond); 2021 Sep; 41(9):867-888. PubMed ID: 34196511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target.
    Liu L; Zhang J; Zhang X; Cheng P; Liu L; Huang Q; Liu H; Ren S; Wei P; Wang C; Dou C; Chen L; Liu X; Zhang H; Chen M
    J Mol Med (Berl); 2021 Jan; 99(1):107-118. PubMed ID: 33128580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells.
    Cornet-Masana JM; Moreno-Martínez D; Lara-Castillo MC; Nomdedeu M; Etxabe A; Tesi N; Pratcorona M; Esteve J; Risueño RM
    Oncotarget; 2016 Apr; 7(17):23239-50. PubMed ID: 26992240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.